Trustee of Dartmouth Medical School and a clinical professor of ophthalmology at New York University. He is past president of American Society of Cataract and Refractive Surgery, president-elect of the International Intraocular Implant Society and is the editor-in-chief of EyeWorld. He has written over 200 peer review papers and 60 book chapters and books. He is a Fellow of the American Academy of Ophthalmology and has received its Lifetime Achievement Award.
Arshad M. Khanani, M.D., M.A., FASRS founded the clinical research section at Sierra Eye Associates, and currently serves as its Managing Partner, Director of Clinical Research, and Director of Fellowship. He has been a principal investigator for more than 120 clinical trials and has authored over 100 scientific publications. He is also a Clinical Associate Professor at the University of Nevada, Reno School of Medicine. Dr. Khanani is an elected member of the Retina Society, Macula Society and has received numerous awards of distinction. He has received the Senior Honor Award from the American Society of Retina Specialists (ASRS) and was also awarded the prestigious ASRS Presidents’ Young Investigator Award in 2021.
Christophe Baudouin, M.D. Ph.D., is professor of Ophthalmology since 1995 and the Chairman of the Department of Ophthalmology in Quinze-Vingts National Ophthalmology Hospital, Paris, as well as the President of the Medical Council since 2016. Pr. Baudouin is also the Director of an INSERM-labelled research group, and a member of the International Council of Ophthalmology (ICO)’s board. He is currently the President of the European Dry Eye Society, Editor-in-Chief of the French Journal of Ophthalmology, Vice-President of the French Glaucoma Society, and an active member of several international societies, including the prestigious American Ophthalmological Society and Academia Ophthalmologica Internationalis. With a Gold Medal Thesis Prize, Pr. Baudouin achieved his M.D. in Nice in 1989 and obtained his Ph.D. in Paris in 1992.
Peter K. Kaiser, M.D., is Chaney Family Endowed Chair in Ophthalmology Research and a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine. Pr. Kaiser is actively involved in clinical research and has been principal investigator in over 60 trials evaluating new treatments for AMD, DR, and other retinal disorders. He is Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, and serves on the editorial boards of American Journal of Ophthalmology, Retina, Retina Today, and Ocular Surgery News. Pr. Kaiser has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Achievement and Senior Achievement Awards and has been listed as one of the top 100 most influential people in the world of ophthalmology. Pr. Kaiser graduated magna cum laude with Highest Honors from Harvard College and magna cum laude from Harvard Medical School.
Anat Loewenstein, M.D., MHA, is Professor of Ophthalmology, Chairman of the Division of Ophthalmology at the Tel Aviv Medical Center, Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at Tel Aviv University, President of the Israeli Ophthalmological Society, and the General Secretary of the EURETINA board. She is a renowned retina specialist, expert in retinal toxicity, and has a strong research interest in the early detection of macular degeneration, among others. She currently serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of Ophthalmology and of Ophthalmologica. Pr. Loewenstein published more than 450 papers in peer reviewed journals and contributed multiple chapters to ophthalmology textbooks. She is also actively involved as a leader in mentorship of young retina specialists including the mentorship educational programs of ARVO and EURETINA.
Quan Dong Nguyen, M.D., MSc, FARVO, FASRS is Professor of Ophthalmology at the Byers Eye Institute, Stanford University School of Medicine. Pr. Nguyen is known for his innovative work in early proof-of-concept, first-in-human clinical studies, and as principal investigator on multiple trials to evaluate potential pharmacotherapeutic agents for ocular inflammation, as well as for retinal vascular and uveitis. He is on the Editorial Board of key journals, including the Journal of Ophthalmic Infection and Inflammation and Ophthalmic Surgery, Lasers and Imaging Retina. He has been elected to many prestigious national and international professional organizations, including the American Academy of Ophthalmology, the Macula Society, the Retina Society, the American Society of Retina Specialists, the Club Jules Gonin, the American Ophthalmological Society, the International Uveitis Study Group, the American Uveitis Society, and the International Ocular Inflammation Society. He completed fellowships in Immunology and Uveitis at the Massachusetts Eye and Ear Infirmary, in Ocular Immunology at the Wilmer Eye Institute of the Johns Hopkins Medical Institutions, and in Medical and Surgical Retina at the Schepens Eye Research Institute and the Massachusetts Eye and Ear Infirmary.
Kuldev Singh is Professor of Ophthalmology and Chief of the Glaucoma Division at the Stanford University School of Medicine. He received an undergraduate degree in Biology and Economics from McGill University, MD and MPH degrees from the Johns Hopkins University followed by residency training at the Casey Eye Institute. He completed a Dana Foundation Fellowship at the Wilmer Eye Institute and a Heed Foundation Fellowship at the Bascom Palmer Eye Institute. Dr. Singh has published over 250 original peer-reviewed articles and delivered over 350 invited lectures including over 70 named or keynote lectures and visiting professorships, edited three textbooks, and served on the editorial boards of 11 ophthalmic publications. His clinical practice focuses on the medical, laser and surgical management of glaucoma and cataract. Dr. Singh has served as President of the American Glaucoma Society, Executive Vice President of the World Glaucoma Association and Board Chair for the Glaucoma Research Foundation. He serves on an FDA Advisory Committee and on the Executive Committee of the UCSF/Stanford Center for Excellence in Regulatory Science and Innovation (CERSI). Dr. Singh has received the World Glaucoma Association Founder’s Award, the Lifetime Achievement Honor Award from the American Academy of Ophthalmology and was inducted into the Delta Omega Public Health Honor Society at the Johns Hopkins University Bloomberg School of Public Health as a distinguished alumnus.
Pablo Villoslada, M.D., is an Adjunct Professor at Stanford University. He has been active in neuroscience and brain diseases research for more than 20 years, contributing to the application of systems biology to neurological diseases, development of new therapies or biomarkers for multiple sclerosis and neuro-ophthalmologic diseases, and developing new neuroimaging technologies for monitoring brain diseases. Prior to taking up his position at Stanford, he was Medical Director of Neuroinflammation at Genentech. His experience also includes roles as Adjunct Professor at the Department of Neurology, University of California, San Francisco, and Group Leader of the Neuroimmunology group of the Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona. He received his M.D. at the University of Santiago de Compostela, Spain in 1990, his speciality in neurology in 1995 at the Hospital Vall d’Hebron, Spain and his PhD in neuroimmunology in 1996 at the Autonomous University of Barcelona.